While this was a continuation of our previous work and the assessment of tumour-infiltrating immune cells was already conducted, we also had not performed a double-staining, which might allow for the PD-L1 expression to be evaluated directly on specific immune cell subtypes. The gene discussed is CD274; the disease is neoplasm.